Aging of the liver graft and functional quality in the absence of recurrent disease: A10 year histological follow-up

Annals of Transplantation

Volumn 15, Issue 1, 2010, Pages 5-13

  Schmeding, Maximilian ^a   Sauer, Igor ^a   Hartwig, Kerstin ^a   Theruvath, Tom ^a   Pratschke, Johann ^a   Neuhaus, Ruth ^a   Neuhaus, Peter ^a   Neumann, Ulf P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alcoholic liver disease; Fibrosis; Liver biopsy; Liver transplantation

Indexed keywords

CYCLOSPORIN A; STEROID; TACROLIMUS;

ADULT; AGING; ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ARTICLE; DISEASE SEVERITY; FATTY LIVER; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE;

EID: 77949829260     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.880562     Document Type: Article

References (29)

1. Sebagh M, Rif'ai K, Feray C et al: All liver recipients benefit from the protocol 10-year liver biopsies. Hematology, 2003; 37: 1293-301
2. Mutimer DJ, Gunson B, Chen J et al: Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation, 2006; 81: 7-14
3. Mandavam S.Jamal MM, Morgan TR: Epidemiology of alcoholic liver disease. Semin Liver Dis, 2004; 24: 217-32
4. Lim JK, Keeffe EB: Liver transplantation for alcoholic liver disease: current concepts and length of sobriety. Liver Transpl, 2004; 10: S31-38
5. De Gottardi A, Spahr L, Gelez P et al: A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med, 2007; 167: 1183-88
6. Lucey MR, Merion RM, Henley KS et al: Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology, 1992; 102: 1736-41
7. Wiesner RH, Lombardero M, Lake J R et al: Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg, 1997; 3: 231-39
8. Pfitzmann R, Schwenzer J, Raves N et al: Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl, 2007; 13: 197-205
9. Cescon M, Grazi GL, Ercolani G et al: Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl, 2003;9:1174-80
10. Nardo B, Masetti M, Urbani L et al: Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant, 2004; 4: 1139-47
11. Nardo B, Montalti R, Beltempo P et al: Octogenarian livers successfully transplanted in patients with fulminant hepatic failure. Transplant Proc, 2005; 37: 389-91
12. Gastaca M, Valdivieso A, Pijoan J et al: Donors older than 70 years in liver transplantation. Transplant Proc, 2005;37:3851-54
13. Zapletal C, Faust D, Wullstein C et al: Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc, 2005; 37: 1182-85
14. Busutlil RW, Tanaka K: The utility of marginal donors in liver transplantation. Liver Transpl, 2003; 9: 651-63
15. Feng S, Goodrich NP, Bragg-Gresham JL et al: Characteristics associated with liver graft failure: the concept of a donor risk index. -Am J Transplant, 2006; 6: 783-90
16. Schaubel DE, Sima CS, Goodrich NP et al: The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor Quality. Am J Transplant, 2008
17. Busquets J, Xiol X, Figueras J et al: The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation, 2001; 71: 1765-71
18. Bahra M, Neumann UP, Jacob D et al: Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C. Transpl hit, 2007; 20: 771-78
19. Berenguer M, Crippin J, Gish R et al: A model to predict severe HCV-related disease following liver transplantation. Hepatology, 2003; 38: 34-41
20. Gordon F: Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues. Liver Transpl, 2006; 12: S73-75
21. Schreibman I, Regev A: Recurrent primary biliary cirrhosis after liver transplantation-the disease and its management. MedGenMed, 2006; 8:30
22. Rifai K, Sebagh M, Karam V et al: Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol, 2004; 41:446-53
23. GavnorJJ, MoonJI, Kato T et al: A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation, 2007; 84: 155-65
24. Neumann UP, Berg T, Bahra M et al: Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.J Hepatol, 2004; 41: 830-36
25. Roavaie K, Feng S: Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Liver Transpl, 2007; 13: S36-43
26. Piscaglia F, Camaggi V, Ravaioli M et al: A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl, 2007; 13: 857-66
27. Fisher RA, Kulik LM, Freise CE et al: Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant, 2007; 7:1601-8
28. Amin MG, Wolf MP, TenBrookJAJr etal: Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl, 2004; 10: 1468-75
29. Merion RM, Schaubel DE, Dykstra DM et al: The survival benefit of liver transplantation. Am J Transplant, 2005; 5: 307-13